Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007190 |
---|---|
Receipt number | R000008367 |
Scientific Title | Bi-weekly capecitabine and oxaliplatin plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer |
Date of disclosure of the study information | 2012/02/01 |
Last modified on | 2018/09/20 08:24:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/01 15:22:55 | ||
2 | Update | 2012/02/01 16:11:24 | Recruitment status |
|
3 | Update | 2012/02/01 17:27:41 | TEL |
|
4 | Update | 2012/06/08 10:25:48 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Email1 |
|
5 | Update | 2012/08/01 13:20:54 | Recruitment status |
|
6 | Update | 2012/08/29 12:55:32 | Email |
|
7 | Update | 2012/08/29 13:03:30 | TEL |
|
8 | Update | 2013/02/01 10:11:48 | Organization1 Address1 Tel1 Email1 |
|
9 | Update | 2013/08/01 23:40:51 | Research ethics review |
|
10 | Update | 2013/09/01 17:32:05 | Email Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL |
|
11 | Update | 2016/04/04 15:14:45 | Name of primary person or sponsor Organization |
|
12 | Update | 2016/08/19 09:43:47 | Recruitment status Publication of results Results |
|
13 | Update | 2016/08/19 10:00:28 | Results Other related information |
|
14 | Update | 2018/09/20 08:24:39 | Recruitment status |